Prostaglandin analog and beta-blocker combination

This page covers all Prostaglandin analog and beta-blocker combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FP receptor (travoprost); beta-2 adrenergic receptor (timolol), Beta-adrenergic receptors, Prostaglandin receptors.

Targets

FP receptor (travoprost); beta-2 adrenergic receptor (timolol) · Beta-adrenergic receptors, Prostaglandin receptors

Marketed (1)

• Travoprost and Timolol · Afyon Kocatepe University Hospital · Ophthalmology
  Travoprost is a prostaglandin F analog that increases uveoscleral outflow of aqueous humor, while timolol is a non-selective beta-blocker that decreases aqueous humor production, together reducing intraocular pressure.

Phase 3 pipeline (1)

• fixed combination latanoprost-timolol · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Ophthalmology
  Latanoprost-timolol is a fixed combination of a prostaglandin analog and a beta-blocker that works by reducing intraocular pressure in the eye.